Androstenedione’s Role in Premature Ovarian Failure (POF): A Dance Between Muscle Mass, Bone Density, and Estrogen Premature ovarian failure (POF), also known as early menopause, affects roughly 1% of women under 40, throwing their hormonal landscape into disarray. This sudden estrogen deficiency triggers a cascade of consequences, including increased osteoporosis risk, decreased muscle mass, and … Continue reading Androstenedione’s Role in Premature Ovarian Failure (POF): A Dance Between Muscle Mass, Bone Density, and Estrogen